ProCE Banner Activity

Expert Insights Into Recent Immunotherapy Advances in CRC

Clinical Thought

In this commentary focused on key clinically relevant questions asked during a live webinar, experts discuss their perspectives on the benefits of immunotherapy for patients with CRC across the disease continuum.

Released: April 23, 2025

Expiration: October 22, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

This educational activity is supported by an independent medical education grant from GSK.

GSK

Disclosure

Primary Author

Christopher Lieu, MD, FASCO: researcher: Genentech, Sanofi; consultant/advisor/speaker: Flatiron Health, Pfizer.

Michael Overman, MD, MSHCT: consultant/advisor/speaker: Amgen, Array, Atreca, Bayer, Bristol Myers Squibb, Janssen, MedImmune, Merck, Nouscom, Pfizer, Roche, Takeda; researcher (paid to institution): Bristol Myers Squibb, Lilly, MedImmune, Merck, Nouscom, Phanes, Roche, Takeda.